HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy.

Abstract
Twelve patients with irresectable or recurrent hilar cholangiocarcinoma were treated with internal biliary drainage followed by intraluminal (iridium-192) and external-beam radiotherapy. Biliary drainage was accomplished by means of a combined surgical and interventional radiological approach. Initial biliary decompression was performed surgically by tumour resection, intrahepatic biliary enteric bypass or distal biliary-enteric anastomosis with a temporary stent. Maintenance of internal biliary drainage and application of intraluminal radiotherapy were accomplished radiologically with the use of percutaneous dilatation and metallic expandable biliary endoprostheses. Median survival was 14.5 months; all 12 patients survived for at least 6 months. Early complications during radiotherapy were minor and included two patients with cholangitis and one with transient haemobilia. Jaundice was relieved in ten of 12 patients, while episodes of cholangitis were seen during long-term follow-up in 11 (median 1.5 episodes per patient). Internal biliary drainage, in conjunction with radiotherapy, appears to be safe and effective palliation of irresectable or recurrent hilar cholangiocarcinoma. Patients can maintain a reasonable quality of life with an acceptable incidence of cholangitis, without the hindrance of external drainage devices.
AuthorsB W Kuvshinoff, J G Armstrong, Y Fong, K Schupak, G Getradjman, N Heffernan, L H Blumgart
JournalThe British journal of surgery (Br J Surg) Vol. 82 Issue 11 Pg. 1522-5 (Nov 1995) ISSN: 0007-1323 [Print] England
PMID8535808 (Publication Type: Journal Article)
Chemical References
  • Iridium Radioisotopes
Topics
  • Aged
  • Bile Duct Neoplasms (radiotherapy, surgery)
  • Brachytherapy (methods)
  • Cholangiocarcinoma (radiotherapy, surgery)
  • Combined Modality Therapy
  • Drainage
  • Female
  • Follow-Up Studies
  • Humans
  • Iridium Radioisotopes (therapeutic use)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Palliative Care
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: